We are live on ! Find out more
BYAH

Park Ha Biological Technology Co

6 hedge funds and large institutions have $57K invested in Park Ha Biological Technology Co in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

50% less funds holding

Funds holding: 126 (-6)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

99% less capital invested

Capital invested by funds: $4.03M → $57K (-$3.97M)

Holders
6
Holders Change
-6
Holders Change %
-50%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
9
Calls
Puts
Net Calls
Net Calls Change

BYAH Hedge Fund Activity: Q3 2025 in Review

6 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q3 2025, worth a combined $57K — down 99% from $4.03M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BYAH and 3 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $136K. The largest seller was Citadel Advisors, exiting entirely with an estimated $743K sold.

  • 6 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q3 2025, down from 12 in Q2 2025.
  • Funds reported $57K of Park Ha Biological Technology Co stock for Q3 2025, down 99% quarter-over-quarter.
  • 3 funds opened new Park Ha Biological Technology Co positions in Q3 2025 and 9 closed out, a net change of -6 holders.
  • The largest Park Ha Biological Technology Co buyer in Q3 2025 was XTX Topco, an estimated $136K added.
  • The largest Park Ha Biological Technology Co seller in Q3 2025 was Citadel Advisors, an estimated $743K sold.

Based on aggregated 13F filings for Q3 2025.